These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15798414)

  • 41. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Impaired Renal Function With Changes in Urinary Mineral Excretion and Stone Composition.
    Patel PM; Kandabarow AM; Druck A; Hart S; Blackwell RH; Kadlec A; Farooq A; Turk TMT; Baldea KG
    Urology; 2020 Jul; 141():45-49. PubMed ID: 32294484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substituting milk for apple juice does not increase kidney stone risk in most normocalciuric adults who form calcium oxalate stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 1998 Mar; 98(3):303-8. PubMed ID: 9508013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
    Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
    Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of 24-hour urinary citrate excretion in stone formers and healthy volunteers.
    Goodarzi MT; Forouzanfar F; Moaddab AH; Karimian M; Sabzevar NK
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1227-31. PubMed ID: 23168853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chung LC; Lee YH; Young TK
    J Formos Med Assoc; 1991 Jan; 90(1):41-7. PubMed ID: 1679108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary citrate excretion in patients with renal calculi.
    Menon M; Mahle CJ
    J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.
    Guerra A; Ticinesi A; Allegri F; Nouvenne A; Pinelli S; Folesani G; Lauretani F; Maggio M; Borghi L; Meschi T
    Urolithiasis; 2016 Nov; 44(6):521-528. PubMed ID: 27038481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors.
    Rodgers AL
    Urol Int; 1997; 58(2):93-9. PubMed ID: 9096270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schedule of taking calcium supplement and the risk of nephrolithiasis.
    Domrongkitchaiporn S; Sopassathit W; Stitchantrakul W; Prapaipanich S; Ingsathit A; Rajatanavin R
    Kidney Int; 2004 May; 65(5):1835-41. PubMed ID: 15086924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum for: "Dietetic and lifestyle recommendations for stone formers." (Arch. Esp. Urol. 2021; 74 (1): 112-122).
    Arch Esp Urol; 2021 Oct; 74(8):725-726. PubMed ID: 34605410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.